Related references
Note: Only part of the references are listed.Chronic neuroleptic treatment combined with a high fat diet elevated [3H] flunitrazepam binding in the cerebellum
Brittany Richardson et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2022)
Goal-directed interaction of stimulus and task demand in the parahippocampal region
Su-Min Lee et al.
HIPPOCAMPUS (2021)
Chronic oral methylphenidate treatment in adolescent rats promotes dose-dependent effects on NMDA receptor binding
Khadija Jalloh et al.
LIFE SCIENCES (2021)
A high-fat diet, but not haloperidol or olanzapine administration, increases activated microglial expression in the rat brain
Marsha Maredia et al.
NEUROSCIENCE LETTERS (2021)
The integrated model of glutamate and dopamine hypothesis for schizophrenia: Prediction and personalized medicine for prevent potential treatment-resistant patients
Li-Chung Huang et al.
MEDICAL HYPOTHESES (2020)
Disrupted Olfactory Integration in Schizophrenia: Functional Connectivity Study
Sara Kiparizoska et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Oral haloperidol or olanzapine intake produces distinct and region-specific increase in cannabinoid receptor levels that is prevented by high fat diet
Foteini Delis et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity
Silvia Sacchi et al.
SCIENTIFIC REPORTS (2017)
Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine
Gavin P. Reynolds et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Effects of long-term treatment with the neuroleptics haloperidol, clozapine and olanzapine on immunoexpression of NMDA receptor subunits NR1, NR2A and NR2B in the rat hippocampus
Marek Krzystanek et al.
PHARMACOLOGICAL REPORTS (2015)
Bardoxolone methyl prevents high-fat diet-induced alterations in prefrontal cortex signalling molecules involved in recognition memory
Danielle Camer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2015)
Schizophrenia symptom and functional correlates of anterior cingulate cortex activation to emotion stimuli: An fMRI investigation
Brady D. Nelson et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2015)
The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies
Wei Hu et al.
YEAR IN NEUROLOGY AND PSYCHIATRY (2015)
Drug models of schizophrenia
Hannah Steeds et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2015)
Substantia Nigra Hyperactivity in Schizophrenia
Stephan Heckers et al.
BIOLOGICAL PSYCHIATRY (2013)
High-fat diets induce changes in hippocampal glutamate metabolism and neurotransmission
Ismael Valladolid-Acebes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?
Jorgen G. Bramness et al.
BMC PSYCHIATRY (2012)
The acute effects of olanzapine on ghrelin secretion, CCK sensitivity, meal size, locomotor activity and body temperature
E. M. van der Zwaal et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
S. Miyamoto et al.
MOLECULAR PSYCHIATRY (2012)
Medial temporal lobe structure and cognition in individuals with schizophrenia and in their non-psychotic siblings
Meghana S. Karnik-Henry et al.
SCHIZOPHRENIA RESEARCH (2012)
Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men
Robert J. Fountaine et al.
OBESITY (2010)
Olanzapine affects locomotor activity and meal size in male rats
Esther M. van der Zwaal et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
The role of the insula in schizophrenia
Korey P. Wylie et al.
SCHIZOPHRENIA RESEARCH (2010)
Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection
Jeffrey A. Lieberman et al.
PHARMACOLOGICAL REVIEWS (2008)
Oral haloperidol or risperidone treatment in rats: Temporal effects on nerve growth factor receptors, cholinergic neurons, and memory performance
A. V. Terry et al.
NEUROSCIENCE (2007)
Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders
Monica Beneyto et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique
S. Hossein Fatemi et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Hippocampal and parahippocampal volumes in schizophrenia: A structural MRI study
K Sim et al.
SCHIZOPHRENIA BULLETIN (2006)
Dorsolateral prefrontal cortex activity during maintenance and manipulation of information in working memory, in patients with schizophrenia
TD Cannon et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia
HT Mueller et al.
MOLECULAR BRAIN RESEARCH (2004)
Serotonin receptors : their key role in drugs to treat schizophrenia
HY Meltzer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: Implications for antipsychotic drug treatment
FI Tarazi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunits
A Schmitt et al.
NEUROCHEMICAL RESEARCH (2003)
Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine
DC Goff et al.
BIOLOGICAL PSYCHIATRY (2002)
Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence
A Carlsson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia
HM Ibrahim et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
N-methyl-D-aspartate (NMDA) receptor-based treatment approaches in schizophrenia: the first decade
U Heresco-Levy
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2000)
Share Paper
